NCT05042882

Brief Summary

Patients suffering from pancreas cancer as well as patients with chronic pancreatitis or requiring pancreas surgery often are in a compromised nutritional status. Nutritional support should therefore be started early during the postoperative course to prevent further malnutrition, as it is an important risk factor to develop complications. Recently, several studies have shown that early enteral nutrition (EEN) could shorten length of stay, reduce postoperative infections and mortality, and decrease costs when compared with total parenteral nutrition (TPN) in gastrointestinal cancer surgery. After pancreatoduodenectomy (PD), EEN has been shown to reduce early and late complications, infections, and readmission rates. It is nevertheless currently not clear if EEN improves the short-term outcomes after PD compared to oral nutrition. The primary objective of the study is to assess the impact of EEN on postoperative morbidity after PD, according to the Comprehensive Complication Index. Secondary objectives are to assess the impact of EEN on major postoperative complications, according to Clavien classification, specific complications, length of stay, readmission rates, quality of life, metabolic stress and nutritional response after PD.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
144

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2021

Typical duration for not_applicable

Geographic Reach
2 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 13, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

December 12, 2021

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 13, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 13, 2025

Completed
Last Updated

April 3, 2025

Status Verified

March 1, 2025

Enrollment Period

3.1 years

First QC Date

August 30, 2021

Last Update Submit

March 28, 2025

Conditions

Keywords

Enteral nutritionOral nutritionPancreatoduodenectomyWhipple operationPancreas surgeryMorbidity

Outcome Measures

Primary Outcomes (1)

  • Comprehensive Complication Index

    Index measuring all complications for a patient

    Postoperative day 90

Secondary Outcomes (9)

  • Severe postoperative complications

    Postoperative day 90

  • Specific complications after pancreatoduodenectomy

    Postoperative day 90

  • Length of stay

    Up to 90 days

  • Readmission

    Postoperative day 90

  • Patients' quality of life

    Preoperatively and at 30 and 90 days after the operation

  • +4 more secondary outcomes

Study Arms (2)

Early enteral nutrition

EXPERIMENTAL

Intervention group: enteral nutrition from the first postoperative night until 50% of caloric requirements are covered by oral nutrition. Enteral nutrition will start at a flow of 250 ml/12h. If tolerated, enteral nutrition will be increased to 500 ml/12h on postoperative day 1, 750 ml/12h on postoperative day 2, and 1000 ml/12h on postoperative day 3. A hypercaloric enteral nutrition will be used (Isosource Energy Fibre or similar).

Dietary Supplement: Early enteral nutrition

Oral nutrition

NO INTERVENTION

Control group: patients will receive standardized oral nutrition. The night after the operation, patients will be allowed to have free drinks. On postoperative day 1, they will receive bouillons, creams, yogurts, and drinks \>2 l. On postoperative day 2, they will receive a light diet. On postoperative day 3, they will receive half portion of normal diet and on postoperative day 4 normal diet.

Interventions

Early enteral nutritionDIETARY_SUPPLEMENT

Enteral nutrition via nasojejunal tube

Early enteral nutrition

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient scheduled for elective open pancreatoduodenectomy.
  • Patient ≥18 years old.
  • Patient at nutritional risk, i.e., with Nutrition Risk Screening (NRS) ≥3.
  • Signed informed consent.

You may not qualify if:

  • Patient not able to give informed consent as documented by signature of consent form (e.g., vulnerable patients).
  • Enteral feeding already initiated preoperatively.
  • Language barrier.
  • Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders (i.e., eating disorders and bipolar disorders), or dementia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Hôpital Cochin-Port Royal, AP-HP

Paris, France

Location

Lausanne University Hospital (CHUV)

Lausanne, Canton of Vaud, Switzerland

Location

Regional Hospital of Lugano

Lugano, Canton Ticino, Switzerland

Location

Related Publications (1)

  • Joliat GR, Martin D, Labgaa I, Melloul E, Uldry E, Halkic N, Fotsing G, Cristaudi A, Majno-Hurst P, Vrochides D, Demartines N, Schafer M. Early enteral vs. oral nutrition after Whipple procedure: Study protocol for a multicentric randomized controlled trial (NUTRIWHI trial). Front Oncol. 2022 Jun 28;12:855784. doi: 10.3389/fonc.2022.855784. eCollection 2022.

MeSH Terms

Conditions

MalnutritionPostoperative Complications

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Gaëtan-Romain Joliat, MD

    University of Lausanne Hospitals

    PRINCIPAL INVESTIGATOR
  • Markus Schäfer, MD

    University of Lausanne Hospitals

    STUDY DIRECTOR
  • Nicolas Demartines, MD

    University of Lausanne Hospitals

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 30, 2021

First Posted

September 13, 2021

Study Start

December 12, 2021

Primary Completion

January 13, 2025

Study Completion

January 13, 2025

Last Updated

April 3, 2025

Record last verified: 2025-03

Locations